Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).
about
Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of N,N-Dialkyl-2-arylindol-3-ylglyoxylamides.Translocator protein (18 kDa): an update on its function in steroidogenesis.Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling.Assessment of TSPO in a Rat Experimental Autoimmune Myocarditis Model: A Comparison Study between [18F]Fluoromethyl-PBR28 and [18F]CB251.Structural Prediction of the Dimeric Form of the Mammalian Translocator Membrane Protein TSPO: A Key Target for Brain Diagnostics
P2860
Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Translocator protein (TSPO) li ...... nt review (2010-2015; part 1).
@en
type
label
Translocator protein (TSPO) li ...... nt review (2010-2015; part 1).
@en
prefLabel
Translocator protein (TSPO) li ...... nt review (2010-2015; part 1).
@en
P2860
P1476
Translocator protein (TSPO) li ...... nt review (2010-2015; part 1).
@en
P2093
Ae Nim Pae
TaeHun Kim
P2860
P304
P356
10.1080/13543776.2016.1230606
P407
P577
2016-09-08T00:00:00Z